摘要
目的探讨2017—2019年高血压药物用药情况。方法采用回顾性分析法对我院2017—2019年高血压药物用药情况进行数据统计,包括高血压用药的药品金额、药品金额占比、金额排名、限定日费用(DDC)、用药频度(DDDs)、DDDs排名及排名比。结果高血压药2017—2019年药品费用排名第一的为钙离子通道阻滞剂(CCB),DDDs最高的是马来酸左旋氨氯地平片、硝苯地平控释片、苯磺酸氨氯地平片,所有降压药物DDC均在20元内。结论2017—2019年高血压用药相对稳定,各种高血压药物在DDC等方面在患者接受范围之内。
Objective To investigate the drug use of hypertension from 2017 to 2019.Methods A retrospective analysis method was used to conduct data statistics on the medication of hypertension in a hospital from 2017 to 2019,including the amount of medication for hypertension,the proportion of medication amount,the ranking of medication amount,the limited daily cost(DDC),the medication frequency(DDDs),the DDDs ranking and the ranking ratio.Results From 2017 to 2019,calcium channel blockers(CCB)ranked the first in terms of drug costs,while levamlodipine maleate,nifedipine controlled release tablets and amlodipine besylate tablets had the highest DDDs.All the DDC of hypotensive drugs were within 20 yuan.Conclusion Medication for hypertension was relatively stable from 2017 to 2019,and various hypertension drugs were accepted by patients in DDC and other aspects.
作者
于海霞
胡坤
YU Haixia;HU Kun(Beijing Xiaotangshan Hospital, Beijing 102211, China.)
出处
《中国老年保健医学》
2021年第1期5-8,共4页
Chinese Journal of Geriatric Care
关键词
高血压用药
销售金额
日均费用
用药频度
用药分析
Hypertension medication
sales amount
average daily cost
medication frequency
medication analysis
